Search

Search Constraints

You searched for: Author/Creator Collins, Christopher E

Search Results

1. 237 Cell bound complement activation products in combination with low complement C3 or C4 have high diagnostic yield in systemic lupus erythematosus. (April 2019)

2. Cell-bound complement activation products associate with lupus severity in SLE. Issue 1 (5th May 2020)

3. Cell-bound complement activation products associate with lupus severity in SLE. Issue 1 (5th May 2020)

4. Cell-bound complement activation products associate with lupus severity in SLE. Issue 1 (5th May 2020)

5. Cell-bound complement activation products associate with lupus severity in SLE. Issue 1 (5th May 2020)

6. Cell-bound complement activation products associate with lupus severity in SLE. Issue 1 (5th May 2020)

7. Cell-bound complement activation products associate with lupus severity in SLE. Issue 1 (5th May 2020)

8. Cell-bound complement activation products associate with lupus severity in SLE. Issue 1 (5th May 2020)

9. Cell-bound complement activation products associate with lupus severity in SLE. Issue 1 (5th May 2020)